Federal Register / Vol. 71, No.
92 / Friday, May 12, 2006 / Notices 27737
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 06–91, Review R03s Data
Analysis & Statistical Methodology.
Date: June 20, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact: Peter Zelazowski, PhD, Scientific
Review Administrator, Scientific Review
Branch, Division of Extramural Activities,
National Inst of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402. 301–593–
4861.peter.zelazowski@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: May 5, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4448 Filed 5–11–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory environmental
Health Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
sroberts on PROD1PC70 with NOTICES
invasion of personal privacy.
Name of Committee: National Advisory
Environmental Health Sciences Council.
Date: June 1, 2006.
Open: 8 a.m. to 2 p.m.
VerDate Aug<31>2005 16:54 May 11, 2006 Jkt 208001
Agenda: Discussion of program policies
and issues.
Place: Nat. Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Nat. Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Contact Person: Anne P. Sassaman, PhD,
Director, Division of Extramural Research
and Training, National Institute of
Environmental Health Sciences, National
Institutes of Health, P.O. Box 12233,
Research Triangle Park, NC 27709. 919/541–
7723.
Any interested person may file written
comments with the committee by forwarding
the statement to the JContact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: http://
www.niehs.nih.gov/dert/c-aagenda.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: May 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4452 Filed 5–11–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\12MYN1.SGM
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: June 8, 2006.
Open: 8 a.m. to 1:30 p.m.
Agenda: (1) A report by the Director,
NICHD; (2) an overview of NICHD intramural
and extramural science; (3) a report of the
Subcommittee on Planning and Policy; and
other business of the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Yvonne T. Maddox, PhD,
Deputy Director, National Institute of Child
Health and Human Development, NIH, 9000
Rockville Pike, MSC 7510, Building 31,
Room 2A03, Bethesda, MD 20892, (301) 496–
1848.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nichd.nih.gov/about/nachhd.htm,
12MYN1
 27738 Federal Register / Vol. 71, No. 92 / Friday, May 12, 2006 / Notices
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS.)
Dated: May 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4454 Filed 5–11–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Neurological
Disorders and Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Clinical Trials Subcommittee.
Date: May 25, 2006.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 9 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
sroberts on PROD1PC70 with NOTICES
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: John Marler, MD,
Associate Director for Clinical Trials,
VerDate Aug<31>2005 18:55 May 11, 2006 Jkt 208001
National Institute of Neurological, Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2216, Bethesda,
MD 20892, (301) 496–9135, jm137f@nih.gov.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Basic and Preclinical Programs
Subcommittee.
Date: May 25, 2006.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 8A–28, Bethesda, MD 20892.
Closed: 9 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 8A–28, Bethesda, MD 20892.
Contact Person: Robert Baughman, MD,
Associate Director for Technology
Development, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892–
9527, (301) 496–1779.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s Home page: http://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: May 4, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4455 Filed 5–11–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following meeting
of the National Commission on
Digestive Diseases.
The meeting will be open to the
public, with attendance limited to space
PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\12MYN1.SGM
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Commission
on Digestive Diseases.
Date: June 12, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: Introduction; review of the state-
of-the science; and overview of the
Commission’s role and responsibilities. Pre-
registration is required. Instructions will be
available on the Commission’s Web site at
http://NCDD.niddk.nih.gov.
Place: Hilton Crystal City at National
Airport, 2399 Jefferson Davis Hwy, (Route 1),
James Room, Arlington, VA 22202.
Contact Person: Stephen P. James, MD,
Director, Division of Digestive Diseases &
Nutrition, National Institute of Diabetes and
Digestive, and Kidney Diseases, NIH, 6707
Democracy Blvd., RM 677, Bethesda, MD
20892–5450, 301–594–7680,
natlcommdd@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: May 5, 2006.
Anna Snouffer,
Acting Director, Office of the Federal Advisory
Committee Policy.
[FR Doc. 06–4460 Filed 5–11–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
12MYN1